NEW THERAPIES IN HUNTINGTON'S DISEASE (HD): CHALLENGES IN MODELLING FOR HEALTH ECONOMIC EVALUATIONS

被引：0
|
作者：
Kirvassilis, N. [1 ]
Patel, A. [2 ]
Thokala, P. [3 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
[2] Roche Prod Ltd, Welwyn Garden City, Herts, England
[3] PT Hlth Econ Ltd, Sheffield, S Yorkshire, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
Huntington's Disease; brain disorder; dementia; economic evaluation; Quality of life; modeling;
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSA124
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] THE HUNTINGTON'S DISEASE NETWORK OF AUSTRALIA (HDNA): PREPARING FOR THE ADVENT OF NEW THERAPIES FOR HD
    Stout, Julie
    Hulme, Audrey
    Davoodi, Mehdi
    O'Regan, Alison
    Wasser, Cory
    Glikmann-Johnston, Yifat
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A39 - A39
  • [2] Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma
    Zou, Huimin
    Xue, Yan
    Chen, Xianwen
    Lai, Yunfeng
    Yao, Dongning
    Ung, Carolina Oi Lam
    Hu, Hao
    [J]. PLOS ONE, 2023, 18 (10):
  • [3] CLINICAL TRANSLATION OF STEM CELL THERAPIES FOR HUNTINGTON'S DISEASE (HD)
    Rosser, Anne
    Busse, Monica
    Gray, William
    Aron-Badin, Romina
    Perrier, Anselm
    Wheelock, Vicki
    Goldman, Steven
    Canals, Josep M.
    Thompson, Leslie
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 : A54 - A54
  • [4] Falling in Huntington's disease (HD)
    Grimbergen, YAM
    Knol, M
    Bloem, BR
    Kremer, HPH
    Roos, RAC
    Munneke, M
    [J]. MOVEMENT DISORDERS, 2005, 20 : S9 - S9
  • [5] The Huntington's Disease Health Index Study (HD-HI)
    Glidden, A.
    Luebbe, E.
    Elson, M.
    Goldenthal, S.
    Dorsey, R.
    Heatwole, C.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [6] A TARGETED LITERATURE REVIEW TO INFORM FUTURE ECONOMIC EVALUATIONS OF HUNTINGTON'S DISEASE
    Munetsi, L.
    Malik, S.
    Guzauskas, G.
    Willock, R.
    Li, N.
    Ali, T.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S400 - S401
  • [7] New therapies in Huntington's disease by directly targeting the brain
    Rosser, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S34 - S34
  • [8] RNAi-based therapies for Huntington's disease: delivery challenges and opportunities
    Mantha, Neelima
    Das, Sudip K.
    Das, Nandita G.
    [J]. THERAPEUTIC DELIVERY, 2012, 3 (09) : 1061 - 1076
  • [9] OBSERVING HUNTINGTON'S DISEASE (HD): THE EUROPEAN HUNTINGTON'S DISEASE NETWORK'S REGISTRY
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A23 - A23
  • [10] Antiglutamate therapies in Huntington's disease
    Kieburtz, K
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (55): : 97 - 102
12345